Find Clinical Trials & Studies
SCD-CARRE Study
I'm Interested!
Please call
1-833-78TRIAL
1-833-78TRIAL
Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE)
- Sex: Any
- Age: Adult (18 - 64), Older Adult (65+)
- Accepting Healthy People: No
- Type: Interventional / Therapeutic
- Trial Phase: Phase III
- Conditions Being Studied: Sickle Cell Anemia
Study Purpose
The purpose of this study is to see the effects of giving long-term red blood cell exchange transfusion to patients with sickle cell disease (SCD). We want to know if exchange blood transfusion may help with complications of SCD or reduce the chances of new serious problems happening.
Who Can Participate
Participants 18 years old and older with a diagnosis of sickle cell disease may be eligible for this study.
Locations
UH Cleveland Medical Center
11100 Euclid Ave
Cleveland OH, 44106
- UH IRB: SITE00001822 (STUDY20221183)
- StudyID: 2022-01082
- ClinicalTrials.gov: NCT04084080
I'm Interested!
Please call
1-833-78TRIAL
1-833-78TRIAL
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL
Cancer Trials: 1-866-373-1464